We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+0.31%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$81.2B
AUM Growth
+$1.02B
Cap. Flow
+$958M
Cap. Flow %
1.18%
Top 10 Hldgs %
10.24%
Holding
4,189
New
550
Increased
1,503
Reduced
1,391
Closed
422

Sector Composition

Rank Sector Weight
1 Technology 14.59%
2 Consumer Discretionary 12.73%
3 Healthcare 11.62%
4 Financials 8.02%
5 Industrials 6.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXS icon
2926
AXIS Capital
AXS
$8.63B
$767K ﹤0.01%
11,493
-20,010
-64% -$1.26M
OPI
2927
CALL
DELISTED
Office Properties Income Trust
OPI
$766K ﹤0.01%
+25,000
New +$698K
ISEE
2928
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$763K ﹤0.01%
681,661
MNR
2929
DELISTED
Monmouth Real Estate Investment Corp
MNR
$763K ﹤0.01%
52,979
+24,489
+86% +$335K
PDD icon
2930
Pinduoduo
PDD
$121B
$761K ﹤0.01%
23,621
-39,918
-63% -$1.07M
CVLT icon
2931
PUT
Commault Systems
CVLT
$6.19B
$760K ﹤0.01%
+17,000
New +$779K
WHR icon
2932
Whirlpool
WHR
$2.44B
$760K ﹤0.01%
4,797
-139,238
-97% -$20M
WPRT
2933
Westport Fuel Systems
WPRT
$33.4M
$759K ﹤0.01%
27,914
-25,866
-48% -$734K
ACRS icon
2934
Aclaris Therapeutics
ACRS
$750M
$758K ﹤0.01%
701,465
+32,206
+5% +$45.7K
AMRN
2935
PUT
Amarin Corp
AMRN
$290M
$758K ﹤0.01%
2,500
SYRS
2936
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$757K ﹤0.01%
7,294
-2,139
-23% -$202K
BSET icon
2937
Bassett Furniture
BSET
$169M
$755K ﹤0.01%
49,361
+2,692
+6% +$35.5K
CTSH icon
2938
PUT
Cognizant
CTSH
$22.3B
$753K ﹤0.01%
12,500
ZUO
2939
CALL
DELISTED
Zuora, Inc.
ZUO
$753K ﹤0.01%
+50,000
New +$753K
NGS icon
2940
Natural Gas Services Group
NGS
$469M
$752K ﹤0.01%
58,731
+15,984
+37% +$219K
VCRA
2941
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$752K ﹤0.01%
30,500
+6,200
+26% +$161K
INCY icon
2942
PUT
Incyte
INCY
$23.7B
$750K ﹤0.01%
10,100
HTLF
2943
DELISTED
Heartland Financial USA, Inc.
HTLF
$750K ﹤0.01%
+16,760
New +$747K
DLPH
2944
CALL
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$750K ﹤0.01%
56,000
+37,500
+203% +$595K
BZUN
2945
Baozun
BZUN
$164M
$749K ﹤0.01%
17,547
-1,672
-9% -$79.5K
CRTO icon
2946
PUT
Criteo
CRTO
$1.05B
$748K ﹤0.01%
40,000
LKSD
2947
DELISTED
LSC Communications, Inc.
LKSD
$748K ﹤0.01%
541,881
+530,127
+4,510% +$983K
FPRX
2948
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$747K ﹤0.01%
192,694
+106,048
+122% +$582K
ATR icon
2949
PUT
AptarGroup
ATR
$8.51B
$746K ﹤0.01%
+6,300
New +$762K
DXCM icon
2950
PUT
DexCom
DXCM
$28.3B
$746K ﹤0.01%
20,000

Similar funds

D.E. Shaw & Co's Q3 2019 Portfolio in Review

As of Q3 2019, D.E. Shaw & Co held 4,189 positions worth $81.2B, up 1.3% from $80.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

D.E. Shaw & Co's Q3 2019 filing shows 550 new, 1,503 increased, 1,391 reduced and 422 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M. The largest sale was Anadarko Petroleum, an estimated $567M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q3 2019 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M.
  • D.E. Shaw & Co added most to PayPal in Q3 2019, an estimated $354M increase.
  • D.E. Shaw & Co's biggest Q3 2019 reduction was Fidelity National Information Services, cutting an estimated $410M.
  • D.E. Shaw & Co fully exited Anadarko Petroleum in Q3 2019, selling an estimated $567M.
  • D.E. Shaw & Co's ten largest holdings make up 10% of its $81.2B portfolio in Q3 2019.
  • D.E. Shaw & Co opened 550 new positions and closed 422 in Q3 2019.
  • D.E. Shaw & Co's portfolio value rose 1.3% quarter-over-quarter to $81.2B.

Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.